Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features. (2018)

First Author: Godfrey AL
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1200/jco.2018.78.8414

PubMed Identifier: 30153096

Publication URI: http://europepmc.org/abstract/MED/30153096

Type: Journal Article/Review

Volume: 36

Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Issue: 34

ISSN: 0732-183X